Dr. Richard Verrier Photo

Richard Verrier, Ph.D.

617-667-0730
Harvard Catalyst Profile
Harvard Title

Associate Professor of Medicine

Administrative and Hospital Titles

Director, Cardiology Grand Rounds

Address

Harvard Institutes of Medicine
77 Avenue Louis Pasteur, Room 223
Boston, MA 02115

Publications View
The Selective Late Sodium Current Inhibitor Eleclazine, Unlike Amiodarone, Does Not Alter Defibrillation Threshold or Dominant Frequency of Ventricular Fibrillation.
Authors: Silva AF, Bonatti R, Batatinha JA, Nearing BD, Zeng D, Belardinelli L, Verrier RL.
J Cardiovasc Pharmacol
View full abstract on Pubmed
Quantitative T-wave alternans analysis for sudden cardiac death risk assessment and guiding therapy: answered and unanswered questions: For: Proceedings of ICE2015 Comandatuba, Brazil, Sudden Death Symposium.
Authors: Verrier RL, Sroubek J.
J Electrocardiol
View full abstract on Pubmed
T-Wave Alternans, Heart Rate Turbulence, and Ventricular Ectopy in Standard versus Daily Hemodialysis: Results from the FHN Daily Trial.
Authors: Kaplan RM, Herzog CA, Larive B, Subacius H, Nearing BD, Verrier R, Passman RS.
Ann Noninvasive Electrocardiol
View full abstract on Pubmed
Baseline elevation and reduction in cardiac electrical instability assessed by quantitative T-wave alternans in patients with drug-resistant epilepsy treated with vagus nerve stimulation in the AspireSR E-36 trial.
Authors: Verrier RL, Nearing BD, Olin B, Boon P, Schachter SC.
Epilepsy Behav
View full abstract on Pubmed
Acute Autonomic Engagement Assessed by Heart Rate Dynamics During Vagus Nerve Stimulation in Patients With Heart Failure in the ANTHEM-HF Trial.
Authors: Nearing BD, Libbus I, Amurthur B, Kenknight BH, Verrier RL.
J Cardiovasc Electrophysiol
View full abstract on Pubmed
Inhibition of the cardiac late sodium current with eleclazine protects against ischemia-induced vulnerability to atrial fibrillation and reduces atrial and ventricular repolarization abnormalities in the absence and presence of concurrent adrenergic st…
Authors: Justo F, Fuller H, Nearing BD, Rajamani S, Belardinelli L, Verrier RL.
Heart Rhythm
View full abstract on Pubmed
Eleclazine, a new selective cardiac late sodium current inhibitor, confers concurrent protection against autonomically induced atrial premature beats, repolarization alternans and heterogeneity, and atrial fibrillation in an intact porcine model.
Authors: Fuller H, Justo F, Nearing BD, Kahlig KM, Rajamani S, Belardinelli L, Verrier RL.
Heart Rhythm
View full abstract on Pubmed
Critical neurocircuitry mediating cardiovascular diseases and strategies for intervention.
Authors: Verrier RL.
Trends Cardiovasc Med
View full abstract on Pubmed
Letter to the Editor--Can reducing quantitative T-wave alternans save lives?
Authors: Libbus I, Nearing BD, Amurthur B, KenKnight BH, Verrier RL.
Heart Rhythm
View full abstract on Pubmed
Unmasking atrial repolarization to assess alternans, spatiotemporal heterogeneity, and susceptibility to atrial fibrillation.
Authors: Verrier RL, Fuller H, Justo F, Nearing BD, Rajamani S, Belardinelli L.
Heart Rhythm
View full abstract on Pubmed